(Q46791719)

English

Tolerability of indacaterol, a novel once-daily beta2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study

scientific article published in December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219838

Tolerability of indacaterol, a novel once-daily beta2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219838

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

William H Yang

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219838

Jean Benoit Martinot

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219838

Petr Pohunek

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219838

Jutta Beier

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219838

Daniel Magula

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219838

Ray Cameron

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219838

Roger Owen

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219838

Mark Higgins

8

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219838

publication date

1 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219838

Annals of Allergy, Asthma & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219838

99

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219838

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219838

555-561

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219838

Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960386-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-response study with high-dose inhaled salmeterol in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960386-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960386-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The biochemical effects of high-dose inhaled salbutamol in patients with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960386-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Indacaterol, a novel inhaled beta2-agonist, provides sustained 24-h bronchodilation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960386-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960386-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960386-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A systematic review of the associations between dose regimens and medication compliance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960386-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Past, present and future--beta2-adrenoceptor agonists in asthma management

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960386-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of catecholamines on plasma potassium: the role of alpha- and beta-adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960386-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse effects of beta-agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960386-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Does tachyphylaxis occur to the non-pulmonary effects of salmeterol?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960386-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960386-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the four formulas of adjusting QT interval for the heart rate in the middle-aged healthy Turkish men.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960386-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and tolerability of indacaterol in asthma: a randomized, placebo-controlled 28-day study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960386-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1081-1206(10)60386-9

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219838

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219838

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46791719&oldid=2132245201"